ASRS
MLTX icon

Arizona State Retirement System’s MoonLake Immunotherapeutics MLTX Stock Holding History

Arizona State Retirement System’s Portfolio MLTX Stock Details MLTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-6,428
Closed -$303K – 2109
2025
Q2 		$303K Buy
6,428
+96
+2% +$3.91K ﹤0.01% 1730
2025
Q1 		$247K Sell
6,332
-39
-0.6% -$1.68K ﹤0.01% 1790
2024
Q4 		$345K Buy
6,371
+35
+0.6% +$1.79K ﹤0.01% 1678
2024
Q3 		$319K Buy
+6,336
New +$297K ﹤0.01% 1728
2024
Q2 		– Sell
-4,942
Closed -$248K – 2136
2024
Q1 		$248K Sell
4,942
-59
-1% -$3.2K ﹤0.01% 1817
2023
Q4 		$302K Sell
5,001
-146
-3% -$7.53K ﹤0.01% 1715
2023
Q3 		$293K Buy
+5,147
New +$284K ﹤0.01% 1676

Other funds holding MLTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Arizona State Retirement System's MLTX Position: Q3 2025 in Review

Arizona State Retirement System sold out of MoonLake Immunotherapeutics (MLTX) in Q3 2025, closing a stake of 6,428 shares — an estimated $303K sold.

Arizona State Retirement System first reported a position in MLTX in Q3 2023 and held it in 7 quarters. The position peaked at $345K in Q4 2024. 134 funds tracked by Wall St. Rank hold MLTX as of Q3 2025.

  • Arizona State Retirement System reported no remaining MoonLake Immunotherapeutics position as of Q3 2025 after selling out during the quarter.
  • Arizona State Retirement System sold 6,428 MoonLake Immunotherapeutics shares in Q3 2025, an estimated $303K.
  • Arizona State Retirement System first reported a position in MoonLake Immunotherapeutics in Q3 2023 and held it in 7 quarters.
  • Arizona State Retirement System's MoonLake Immunotherapeutics position peaked at $345K in Q4 2024.
  • 134 funds tracked by Wall St. Rank held MoonLake Immunotherapeutics as of Q3 2025.

Based on Arizona State Retirement System's 13F filing for Q3 2025, filed 3 Nov 2025.